Clinical Trial Update: The Effect of Rimonabant on Energy Expenditure, Fat Metabolism and Body Composition [Phase 4]

View source ↗

Summary

Phase 4 study evaluating rimonabant on energy expenditure, fat metabolism, and body composition in obesity has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Rimonabant (rimonabant)

Snippet

Sponsor: University of Surrey | Conditions: Obesity | Phase 4 | Status: TERMINATED